- Report
- January 2026
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 364 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 283 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 285 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 368 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 364 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 276 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 529 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 216 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 140 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- October 2025
- 147 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- September 2025
- 141 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- August 2025
- 136 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- May 2025
- 139 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- April 2025
- 146 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- August 2025
- 223 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- August 2025
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 145 Pages
Global
From €3459EUR$3,950USD£3,003GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more